Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
TER
0.59% p.a.
Distribution policy
Accumulating
Replication
Physical
Fund size
GBP 7 m
Inception Date
4 April 2019
Holdings
101
Advertisement
Capital at risk
Overview
Advertisement
Start now: Build your own ETF with Pies, choosing from 13,000 stocks & ETFs. Open account Capital at risk. Execution-only services.
Description
The HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF seeks to track the Indxx Advanced Life Sciences & Smart Healthcare Thematic index. Der Indxx Advanced Life Sciences & Smart Healthcare Thematic index tracks global companies involved in sectors from robotics to bioinformatics.
Chart
Basics
Data
| Index | Indxx Advanced Life Sciences & Smart Healthcare Thematic |
| Investment focus | Equity, World, Health Care |
| Fund size | GBP 7 m |
| Total expense ratio | 0.59% p.a. |
| Replication | Physical (Optimized sampling) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 28.01% |
| Inception/ Listing Date | 4 April 2019 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | HANetf |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | J.P. Morgan Administration Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | J.P. Morgan SE - Dublin Branch |
| Revision Company | Ernst and Young |
| Fiscal Year End | 31 March |
| Swiss representative | Waystone |
| Swiss paying agent | Helvitsche Bank |
| Germany | Unknown |
| Switzerland | No ESTV Reporting |
| Austria | Non-Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
Similar ETFs
This section provides you with information on other ETFs with a similar investment focus to the HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our ETF profile? Here you'll find our Questionnaire.
Holdings
Below you find information about the composition of the HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF.
Top 10 Holdings
Weight of top 10 holdings
out of 101
17.58%
| Hims & Hers Health | 2.51% |
| Telix Pharmaceuticals | 2.00% |
| Natera | 1.92% |
| PeptiDream Inc. | 1.91% |
| Sarepta Therapeutics | 1.86% |
| PROCEPT BioRobotics | 1.53% |
| Glaukos | 1.48% |
| Boston Scientific Corp. | 1.48% |
| Twist Bioscience | 1.45% |
| Lantheus Holdings, Inc. | 1.44% |
Sectors
| Health Care | 91.94% |
| Consumer Staples | 1.61% |
| Consumer Discretionary | 1.53% |
| Other | 4.93% |
As of 28/06/2024
Performance
Returns overview
| YTD | +15.93% |
| 1 month | +0.26% |
| 3 months | +14.87% |
| 6 months | +14.18% |
| 1 year | +18.28% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 28.01% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | 0.65 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | - |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | - |
Rolling 1 year volatility
Stock exchange
Listings
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Stuttgart Stock Exchange | EUR | W311 | - - | - - | - |
| Frankfurt Stock Exchange | EUR | - | W311 GY WELLEUIV | W311.DE WELLEURINAV=SOLA | RBC Europe Ltd |
| XETRA | EUR | W311 | WELLEUIV | WELLEURINAV=SOLA | RBC Europe Ltd |
Further information
Further ETFs with similar investment focus
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 916 | 0.40% p.a. | Accumulating | Sampling |
| L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 177 | 0.49% p.a. | Accumulating | Full replication |
| L&G Pharma Breakthrough UCITS ETF | 16 | 0.49% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 13 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 1C | 7 | 0.30% p.a. | Accumulating | Full replication |
Latest articles
Frequently asked questions
What is the name of W311?
The name of W311 is HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF.
What is the ticker of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The primary ticker of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is W311.
What is the ISIN of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The ISIN of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is DE000A2PE7K4.
What are the costs of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The total expense ratio (TER) of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF amounts to 0.59% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF paying dividends?
HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The fund size of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is 7m GBP. See the following article for more information about the size of ETFs.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.